Infliximab: Efficacy in psoriasis. | Indian J Dermatol Venereol Leprol; 2013 Jul; 79(Suppl_7):s25-s34 | IMSEAR

Main content 1 Search 2 Footer 3

+A A -A High contrast

Infliximab: Efficacy in psoriasis.

Arsiwala, Shehnaz.

Indian J Dermatol Venereol Leprol ; 2013 Jul; 79(Suppl_7):s25-s34

Article in En | IMSEAR | ID: sea-154743

Subject(s)

Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/therapeutic use; Asia; Dermatologic Agents/administration & dosage; Dermatologic Agents/therapeutic use; Disease Progression; Guidelines as Topic; Humans; Psoriasis/drug therapy; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Key words

Infliximab; psoriasis; tumor necrosis factor-α

Search on Google

Full text: 1 Index: IMSEAR Main subject: Psoriasis / Asia / Humans / Tumor Necrosis Factor-alpha / Guidelines as Topic / Disease Progression / Dermatologic Agents / Antibodies, Monoclonal Type of study: Guideline Country/Region as subject: Asia Language: En Journal: Indian J Dermatol Venereol Leprol Year: 2013 Type: Article

Search on Google

Full text: 1 Index: IMSEAR Main subject: Psoriasis / Asia / Humans / Tumor Necrosis Factor-alpha / Guidelines as Topic / Disease Progression / Dermatologic Agents / Antibodies, Monoclonal Type of study: Guideline Country/Region as subject: Asia Language: En Journal: Indian J Dermatol Venereol Leprol Year: 2013 Type: Article